Oncology Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China.
Mol Med Rep. 2018 Apr;17(4):5764-5773. doi: 10.3892/mmr.2018.8616. Epub 2018 Feb 16.
MDA7/IL24 is a member of the IL‑10 gene family that functions as a cytokine. Notably, supra‑physiological endogenous MDA7 levels have been indicated to suppress tumor growth and induce apoptosis in different cancer types. In the present study, MDA7 roles were investigated during the proliferation of hepatocellular carcinoma (HCC) cells and the molecular mechanisms underlying this process. A lentiviral vector expressing MDA7/IL24 (LV‑MDA7/IL24) was constructed and used to infect HCC SMMC‑7721 cells. The expression levels of MDA7/IL24 in these cells were determined using RT‑qPCR and western blot analysis. The effects of LV‑MDA7/IL24 on cell proliferation were analyzed using MTT and colony formation assays. Furthermore, the influence of LV‑MDA7/IL24 on cell apoptosis and cell cycle distribution were detected using flow cytometry. The underlying molecular mechanisms were investigated using microarray and western blot analysis. The expression of MDA7/IL24 was confirmed to be significantly increased in the cells infected with LV‑MDA7/IL24 compared with that the negative‑control infected group. Lentivirus‑mediated MDA7/IL24 expression was found to inhibit HCC cell proliferation and colony formation, and it also induced cell arrest and apoptosis. Microarray analysis and western blotting results indicated that multiple cancer‑associated pathways and oncogenes are regulated by MDA7/IL24, including cell cycle regulatory and apoptosis activation pathway. In conclusion, it was determined that MDA7/IL24 inhibits the proliferation and reduces the tumorigenicity of HCC cells by regulating cell cycle progression and inducing apoptosis, indicating that it may be used as a potential prognostic and therapeutic target in HCC.
MDA7/IL24 是白细胞介素 10 基因家族的成员,作为细胞因子发挥作用。值得注意的是,超生理内源性 MDA7 水平已被表明可抑制不同癌症类型的肿瘤生长并诱导细胞凋亡。在本研究中,研究了 MDA7 在肝癌 (HCC) 细胞增殖过程中的作用及其潜在的分子机制。构建了表达 MDA7/IL24 的慢病毒载体 (LV-MDA7/IL24) 并用于感染 HCC SMMC-7721 细胞。使用 RT-qPCR 和 Western blot 分析检测这些细胞中 MDA7/IL24 的表达水平。使用 MTT 和集落形成测定分析 LV-MDA7/IL24 对细胞增殖的影响。此外,通过流式细胞术检测 LV-MDA7/IL24 对细胞凋亡和细胞周期分布的影响。使用微阵列和 Western blot 分析研究潜在的分子机制。结果证实,与阴性对照感染组相比,感染 LV-MDA7/IL24 的细胞中 MDA7/IL24 的表达显著增加。慢病毒介导的 MDA7/IL24 表达被发现抑制 HCC 细胞增殖和集落形成,并且还诱导细胞停滞和凋亡。微阵列分析和 Western blot 结果表明,MDA7/IL24 调节多种癌症相关途径和癌基因,包括细胞周期调控和凋亡激活途径。总之,研究结果表明 MDA7/IL24 通过调节细胞周期进程和诱导细胞凋亡抑制 HCC 细胞的增殖并降低其致瘤性,表明它可能作为 HCC 的潜在预后和治疗靶点。